(Q24241094)

https://api.crossref.org/works/10.1002%2F14651858.CD001402.PUB2

Neonatal screening for cystic fibrosis in Wales and the West Midlands: 1. Evaluation of immunoreactive trypsin test

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001402.PUB2

Early diagnosis of cystic fibrosis through neonatal screening prevents severe malnutrition and improves long-term growth. Wisconsin Cystic Fibrosis Neonatal Screening Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001402.PUB2

Evidence on improved outcomes with early diagnosis of cystic fibrosis through neonatal screening: enough is enough!

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001402.PUB2

Bronchopulmonary disease in children with cystic fibrosis after early or delayed diagnosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001402.PUB2

Longitudinal evaluation of bronchopulmonary disease in children with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001402.PUB2

Acquisition of Pseudomonas aeruginosa in children with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001402.PUB2

Newborn screening for cystic fibrosis in Wisconsin: comparison of biochemical and molecular methods.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001402.PUB2

Quality of life of children with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001402.PUB2

Cognitive function of children with cystic fibrosis: deleterious effect of early malnutrition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001402.PUB2

Comprehensive analysis of risk factors for acquisition of Pseudomonas aeruginosa in young children with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001402.PUB2

Analysis of the costs of diagnosing cystic fibrosis with a newborn screening program

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001402.PUB2

Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001402.PUB2

Longitudinal pulmonary status of cystic fibrosis children with meconium ileus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001402.PUB2

Temporal associations among energy intake, plasma linoleic acid, and growth improvement in response to treatment initiation after diagnosis of cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001402.PUB2

Lower airway inflammation in infants and young children with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001402.PUB2

Long term prognosis of patients with cystic fibrosis in relation to early detection by neonatal screening and treatment in a cystic fibrosis centre

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001402.PUB2

Cystic fibrosis: current survival and population estimates to the year 2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001402.PUB2

Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001402.PUB2

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001402.PUB2

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001402.PUB2

Neonatal screening for cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001402.PUB2

Clinical outcomes of newborn screening for cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001402.PUB2

Nutritional status of infants with cystic fibrosis associated with early diagnosis and intervention

21 January 2018

1 reference

12 December 2020

Cystic fibrosis newborn screening: impact on reproductive behavior and implications for genetic counseling

1 reference

12 December 2020

Recovery of birth weight z score within 2 years of diagnosis is positively associated with pulmonary status at 6 years of age in children with cystic fibrosis

1 reference

12 December 2020

Cystic fibrosis newborn screening: impact of early screening results on parenting stress

1 reference

12 December 2020

Cystic fibrosis mutations and genotype-pulmonary phenotype analysis

1 reference

12 December 2020

Cystic fibrosis newborn screening: a pilot study to maximize carrier screening

1 reference

12 December 2020

Does early detection lead to an improved prognosis in cystic fibrosis neonates?

1 reference

12 December 2020

Newborn screening for cystic fibrosis is complicated by age-related decline in immunoreactive trypsinogen levels

1 reference

12 December 2020

Newborn screening for cystic fibrosis. The Cystic Fibrosis Neonatal Screening Study Group

1 reference

12 December 2020

The relationship between infection and inflammation in the early stages of lung disease from cystic fibrosis

1 reference

12 December 2020

Nutritional status of patients with cystic fibrosis with meconium ileus: a comparison with patients without meconium ileus and diagnosed early through neonatal screening

1 reference

12 December 2020

Severe hemolytic anemia associated with vitamin E deficiency in infants with cystic fibrosis. Implications for neonatal screening

1 reference

12 December 2020

Early Pulmonary Inflammation in Infants with Cystic Fibrosis

1 reference

12 December 2020

Nutritional assessment of infants with cystic fibrosis diagnosed through screening

1 reference

12 December 2020

Psychological impact of false-positive results when screening for cystic fibrosis.

1 reference

12 December 2020

Attitudes of parents of cystic fibrosis children towards neonatal screening and antenatal diagnosis

1 reference

12 December 2020

Parents' knowledge of neonatal screening and response to false-positive cystic fibrosis testing

1 reference

12 December 2020

Nutritional benefits of neonatal screening for cystic fibrosis. Wisconsin Cystic Fibrosis Neonatal Screening Study Group

1 reference

12 December 2020

Laboratory quality control issues related to screening newborns for cystic fibrosis using immunoreactive trypsin

1 reference

12 December 2020

A prospective randomized trial of early diagnosis and treatment of cystic fibrosis: a unique ethical dilemma.

1 reference

12 December 2020

Improving the health of patients with cystic fibrosis through newborn screening. Wisconsin Cystic Fibrosis Neonatal Screening Study Group

1 reference

12 December 2020

Cystic fibrosis-related deaths in infancy and the effect of newborn screening

1 reference

12 December 2020

Neonatal screening for cystic fibrosis: position paper

1 reference

12 December 2020

Effect of linoleic acid intake on growth of infants with cystic fibrosis

1 reference

12 December 2020

Psychological impact of false-positive results when screening for cystic fibrosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001402.PUB2

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1002/14651858.CD001402.PUB2

0 references

Fatcat ID

release_5s4hx6rc6barnirbv75t5ak3rm

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/5s4hx6rc6barnirbv75t5ak3rm

24 November 2022